Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide for prevention of postoperative hyponatremia after TURP
IRCT20211208053328N2Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of furosemide in hyponatraemia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Serum sodium, Serum potassium and 2 more. Started Aug 2022; status: completed.
02
Drugs
furosemide
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on IRCT20211208053328N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211208053328N2.